Annual EBITDA
-$99.28 M
+$32.44 M+24.63%
December 31, 2023
Summary
- As of February 8, 2025, PASG annual EBITDA is -$99.28 million, with the most recent change of +$32.44 million (+24.63%) on December 31, 2023.
- During the last 3 years, PASG annual EBITDA has risen by +$11.82 million (+10.64%).
- PASG annual EBITDA is now -883.44% below its all-time high of -$10.10 million, reached on December 31, 2018.
Performance
PASG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$15.15 M
+$995.00 K+6.16%
September 30, 2024
Summary
- As of February 8, 2025, PASG quarterly EBITDA is -$15.15 million, with the most recent change of +$995.00 thousand (+6.16%) on September 30, 2024.
- Over the past year, PASG quarterly EBITDA has increased by +$7.18 million (+32.14%).
- PASG quarterly EBITDA is now -262.83% below its all-time high of -$4.17 million, reached on March 1, 2019.
Performance
PASG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$66.17 M
+$7.18 M+9.78%
September 30, 2024
Summary
- As of February 8, 2025, PASG TTM EBITDA is -$66.17 million, with the most recent change of +$7.18 million (+9.78%) on September 30, 2024.
- Over the past year, PASG TTM EBITDA has increased by +$42.76 million (+39.25%).
- PASG TTM EBITDA is now -1485.01% below its all-time high of -$4.17 million, reached on March 1, 2019.
Performance
PASG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PASG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.6% | +32.1% | +39.3% |
| 3 y3 years | +10.6% | +32.1% | +39.3% |
| 5 y5 years | -883.4% | +32.1% | +39.3% |
PASG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.6% | at high | +69.4% | at high | +63.1% |
| 5 y | 5-year | -171.6% | +43.6% | -11.8% | +69.4% | -81.0% | +63.1% |
| alltime | all time | -883.4% | +43.6% | -262.8% | +69.4% | -1485.0% | +63.1% |
Passage Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.15 M(-6.2%) | -$66.17 M(-9.8%) |
| Jun 2024 | - | -$16.14 M(-6.4%) | -$73.35 M(-10.1%) |
| Mar 2024 | - | -$17.24 M(-2.2%) | -$81.62 M(-17.8%) |
| Dec 2023 | -$99.28 M(-24.6%) | -$17.64 M(-21.0%) | -$99.28 M(-8.9%) |
| Sep 2023 | - | -$22.32 M(-8.5%) | -$108.94 M(-2.5%) |
| Jun 2023 | - | -$24.41 M(-30.1%) | -$111.71 M(-11.5%) |
| Mar 2023 | - | -$34.91 M(+27.9%) | -$126.19 M(-4.2%) |
| Dec 2022 | -$131.72 M(-25.2%) | -$27.30 M(+8.8%) | -$131.72 M(-14.4%) |
| Sep 2022 | - | -$25.10 M(-35.5%) | -$153.91 M(-9.4%) |
| Jun 2022 | - | -$38.89 M(-3.8%) | -$169.95 M(-5.3%) |
| Mar 2022 | - | -$40.43 M(-18.3%) | -$179.39 M(+1.8%) |
| Dec 2021 | -$176.19 M | -$49.49 M(+20.3%) | -$176.19 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$41.14 M(-14.9%) | -$164.47 M(+8.4%) |
| Jun 2021 | - | -$48.33 M(+29.8%) | -$151.69 M(+16.3%) |
| Mar 2021 | - | -$37.22 M(-1.5%) | -$130.46 M(+17.4%) |
| Dec 2020 | -$111.10 M(+203.9%) | -$37.78 M(+33.2%) | -$111.10 M(+27.9%) |
| Sep 2020 | - | -$28.36 M(+4.6%) | -$86.87 M(+23.9%) |
| Jun 2020 | - | -$27.11 M(+51.7%) | -$70.12 M(+39.6%) |
| Mar 2020 | - | -$17.86 M(+31.9%) | -$50.24 M(+37.4%) |
| Dec 2019 | -$36.55 M(+262.1%) | -$13.55 M(+16.8%) | -$36.55 M(+58.9%) |
| Sep 2019 | - | -$11.60 M(+60.4%) | -$23.01 M(+101.7%) |
| Jun 2019 | - | -$7.23 M(+73.2%) | -$11.41 M(+173.2%) |
| Mar 2019 | - | -$4.17 M | -$4.17 M |
| Dec 2018 | -$10.10 M | - | - |
FAQ
- What is Passage Bio annual EBITDA?
- What is the all time high annual EBITDA for Passage Bio?
- What is Passage Bio annual EBITDA year-on-year change?
- What is Passage Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Passage Bio?
- What is Passage Bio quarterly EBITDA year-on-year change?
- What is Passage Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Passage Bio?
- What is Passage Bio TTM EBITDA year-on-year change?
What is Passage Bio annual EBITDA?
The current annual EBITDA of PASG is -$99.28 M
What is the all time high annual EBITDA for Passage Bio?
Passage Bio all-time high annual EBITDA is -$10.10 M
What is Passage Bio annual EBITDA year-on-year change?
Over the past year, PASG annual EBITDA has changed by +$32.44 M (+24.63%)
What is Passage Bio quarterly EBITDA?
The current quarterly EBITDA of PASG is -$15.15 M
What is the all time high quarterly EBITDA for Passage Bio?
Passage Bio all-time high quarterly EBITDA is -$4.17 M
What is Passage Bio quarterly EBITDA year-on-year change?
Over the past year, PASG quarterly EBITDA has changed by +$7.18 M (+32.14%)
What is Passage Bio TTM EBITDA?
The current TTM EBITDA of PASG is -$66.17 M
What is the all time high TTM EBITDA for Passage Bio?
Passage Bio all-time high TTM EBITDA is -$4.17 M
What is Passage Bio TTM EBITDA year-on-year change?
Over the past year, PASG TTM EBITDA has changed by +$42.76 M (+39.25%)